CapsoVision

CV · NASDAQ

$6.68+$0.01 (+0.15%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $6.67

About CV

CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California and currently employs 28 full-time employees. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

Employees: 28
Headquarters: Saratoga California, California
Listed: Jul 2, 2025
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: capsovision.com

Leadership

CapsoVision executives
Name	Title	Since	Age
Chen Lung Tsai	—	—	73
Kang-Huai Wang	—	2006	68
David Garcia	—	—	51
Douglas Atkinson	—	—	57
Keri Jorgenson	—	—	—
Min-Liang Chen	—	—	—
Eliyahou Harari	—	—	—
Howard Lee	—	—	—
Heidi Chung Sutardja	—	—	—
Pen-Jung Tseng	—	—	—
Julia Gouw	—	—	65
Joanne Imperial	—	—	75
Wen-Herng King	—	—	61
Hui Ying Kuo	—	—	54

Similar companies

Companies in the same industry as CapsoVision

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.